StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.35−0.03 (-7.03%)

Close on Nov 18, 2026Market cap $1.83MP/E –Yield –

Jaguar Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Jaguar Health's operating income for the twelve months ending Jun 30, 2026 was -$25.90M. For fiscal 2025 it was -$45.91M. The highest annual figure on record is -$8.32M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$45.91M–
FY2024Dec 31, 2024-$30.83M–
FY2023Dec 31, 2023-$34.29M–
FY2022Dec 31, 2022-$34.42M–
FY2021Dec 31, 2021-$40.71M–
FY2020Dec 31, 2020-$26.65M–
FY2019Dec 31, 2019-$28.95M–
FY2018Dec 31, 2018-$30.82M–
FY2017Dec 31, 2017-$34.25M–
FY2016Dec 31, 2016-$13.59M–
FY2015Dec 31, 2015-$12.45M–
FY2014Dec 31, 2014-$8.32M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.60M–
Q1 FY2026Mar 31, 2026$10.18M–
Q4 FY2025Dec 31, 2025-$21.24M–
Q3 FY2025Sep 30, 2025-$7.24M–
Q2 FY2025Jun 30, 2025-$8.01M–
Q1 FY2025Mar 31, 2025-$9.42M–
Q4 FY2024Dec 31, 2024-$8.16M–
Q3 FY2024Sep 30, 2024-$7.26M–
Q2 FY2024Jun 30, 2024-$7.20M–
Q1 FY2024Mar 31, 2024-$8.22M–
Q4 FY2023Dec 31, 2023-$7.56M–
Q3 FY2023Sep 30, 2023-$8.79M–
Q2 FY2023Jun 30, 2023-$8.10M–
Q1 FY2023Mar 31, 2023-$9.85M–
Q4 FY2022Dec 31, 2022-$6.29M–
Q3 FY2022Sep 30, 2022-$9.90M–
Q2 FY2022Jun 30, 2022-$6.48M–
Q1 FY2022Mar 31, 2022-$11.75M–
Q4 FY2021Dec 31, 2021-$10.82M–
Q3 FY2021Sep 30, 2021-$9.53M–
Q2 FY2021Jun 30, 2021-$11.58M–
Q1 FY2021Mar 31, 2021-$8.77M–
Q4 FY2020Dec 31, 2020-$5.17M–
Q3 FY2020Sep 30, 2020-$5.38M–
Q2 FY2020Jun 30, 2020-$8.45M–
Q1 FY2020Mar 31, 2020-$7.65M–
Q4 FY2019Dec 31, 2019-$5.82M–
Q3 FY2019Sep 30, 2019-$6.73M–
Q2 FY2019Jun 30, 2019-$10.62M–
Q1 FY2019Mar 31, 2019-$5.78M–
Q4 FY2018Dec 31, 2018-$12.11M–
Q3 FY2018Sep 30, 2018-$6.51M–
Q4 FY2017Dec 31, 2017-$20.68M–
Q3 FY2017Sep 30, 2017-$7.34M–
Q2 FY2017Jun 30, 2017-$2.35M–
Q1 FY2017Mar 31, 2017-$3.88M–
Q4 FY2016Dec 31, 2016-$3.31M–
Q3 FY2016Sep 30, 2016-$3.18M–
Q2 FY2016Jun 30, 2016-$3.41M–

More Jaguar Health figures

See a number that looks wrong?